By Shelly Fan – singularity hub
With just a single injection, a new treatment transforms immune cells in cancer patients into efficient tumor-killing machines. Now equipped with homing beacons, the cells rapidly track down and destroy their cancerous foes.
The shot is based on CAR T cell therapy, a breakthrough that uses genetic engineering to supercharge cancer-fighting T cells. Since its first FDA approval in 2017, CAR T has vanquished some deadly cancer cases with a one-and-done treatment.